Plain-English translation of NCT07394959 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new approach to IV fluid management during heart procedures in older adults with kidney problems. The study uses a remote sensor system to monitor how much fluid is in your lungs and adjusts your IV fluids in real time. The goal is to protect your kidneys from injury caused by contrast dye used during the procedure, while preventing your heart from being overwhelmed by too much fluid.
Older patients with kidney disease face a tough choice during heart procedures: they need extra fluids to protect their kidneys from contrast dye damage, but too much fluid can cause dangerous fluid buildup in the lungs and heart problems. This trial is testing whether smart, real-time fluid monitoring can solve this problem by giving you exactly the right amount of fluid.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to one of two groups. One group will receive IV fluids guided by a lung water monitoring sensor that adjusts your fluid rate throughout your heart procedure and recovery. The other group will receive standard IV fluids according to normal guidelines. Either way, doctors will monitor you for kidney injury and heart problems during your hospital stay and follow up with you afterward to check on your kidney function and any heart events.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
China